Nandabalan Krishnan has filed 14 insider transactions across 1 company since November 2022.
Most recent transaction: a option exercise of 60000 shares of BioXcel Therapeutics, Inc. ($BTAI) on April 06, 2023.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 6, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Nandabalan Krishnan | Director | M | Common Stock | 60000 | $0.41 | 8,606,750.0000 | 28,616,000 | 0.70% | 0.21% |
| April 6, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Nandabalan Krishnan | Director | S | Common Stock | 60000 | $17.32 | 8,546,750.0000 | 28,616,000 | 0.70% | 0.21% |
| April 6, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Nandabalan Krishnan | Director | M | Stock Options | 60000 | $0.00 | 294,000.0000 | 28,616,000 | 16.95% | 0.21% |
| Nov. 15, 2022 | BioXcel Therapeutics, Inc. | $BTAI | Nandabalan Krishnan | Director | G | Common Stock | 145549 | $0.00 | 8,546,750.0000 | 28,022,000 | 1.67% | 0.52% |
| Nov. 15, 2022 | BioXcel Therapeutics, Inc. | $BTAI | Nandabalan Krishnan | Director | G | Common Stock | 291097 | $0.00 | 8,546,750.0000 | 28,022,000 | 3.29% | 1.04% |
| Nov. 15, 2022 | BioXcel Therapeutics, Inc. | $BTAI | Nandabalan Krishnan | Director | G | Common Stock | 291097 | $0.00 | 8,546,750.0000 | 28,022,000 | 3.53% | 1.04% |
| Jan. 4, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Nandabalan Krishnan | Director | M | Common Stock | 34111 | $0.41 | 8,580,861.0000 | 28,015,000 | 0.40% | 0.12% |
| Jan. 4, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Nandabalan Krishnan | Director | S | Common Stock | 24290 | $21.59 | 8,556,571.0000 | 28,015,000 | 0.28% | 0.09% |
| Jan. 4, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Nandabalan Krishnan | Director | S | Common Stock | 9821 | $22.21 | 8,546,750.0000 | 28,015,000 | 0.11% | 0.04% |
| Jan. 5, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Nandabalan Krishnan | Director | M | Common Stock | 25889 | $0.41 | 8,572,639.0000 | 28,015,000 | 0.30% | 0.09% |
| Jan. 5, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Nandabalan Krishnan | Director | S | Common Stock | 25089 | $22.32 | 8,547,550.0000 | 28,015,000 | 0.29% | 0.09% |
| Jan. 5, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Nandabalan Krishnan | Director | S | Common Stock | 800 | $22.93 | 8,546,750.0000 | 28,015,000 | 0.01% | 0.00% |
| Jan. 4, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Nandabalan Krishnan | Director | M | Stock Options | 34111 | $0.00 | 379,889.0000 | 28,015,000 | 8.24% | 0.12% |
| Jan. 5, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Nandabalan Krishnan | Director | M | Stock Options | 25889 | $0.00 | 354,000.0000 | 28,015,000 | 6.81% | 0.09% |